Coronavirus Disease 2019 (COVID-19) Clinical Trials – Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The purpose of this report is to provide insight into the overall clinical trial landscape for COVID-19 clinical trials, trials using vaccines vs. therapeutics, and trials impacted by COVID-19.
Scope
The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included clinical trials that were captured in the database as of April 22, 2021. The trials were analyzed and segmented by all COVID-19 trials, trials using vaccines, trials using therapeutics, and non-COVID-19 trials impacted due to the pandemic. Further analysis was conducted based on multinational vs. single country, clinical trial sites, status, primary endpoint status, terminated trials, phase, sponsor type, and upcoming milestone events.
Reasons to Buy
Understand the global COVID-19 landscape
The trends of vaccine COVID-19 clinical trials
The trends of therapeutic COVID-19 clinical trials
A closer look at the impact of the pandemic on non-COVID-19 trials
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.